| Record ID | marc_records_scriblio_net/part21.dat:57514163:804 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part21.dat:57514163:804?format=raw |
LEADER: 00804pam 2200229 a 4500
001 90001381
003 DLC
005 19900827094145.0
008 900123s1989 dcua 00000 eng
010 $a 90001381
020 $a1558711562 :$c$95.00
040 $aDLC$cDLC$dDLC
043 $an-us---
050 00 $aHD9999.B443$bU614 1989
082 00 $a338.4/36606/0973$220
245 04 $aThe Biotech business :$bfinancial outlook and analysis.
260 0 $aWashington, D.C. :$bSpecial Projects Unit of the Bureau of National Affairs,$cc1989.
300 $av, 134 p. :$bill. ;$c28 cm.
440 4 $aThe BNA special report series on biotechnology ;$vspecial report #3
500 $aCover title.
650 0 $aBiotechnology industries$zUnited States$xFinance.
710 20 $aBureau of National Affairs (Washington, D.C.)